tiprankstipranks
Trending News
More News >
Welby Inc. (JP:4438)
:4438
Japanese Market

Welby Inc. (4438) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Welby Inc.

(4438)

Rating:53Neutral
Price Target:
¥369.00
▲(0.27%Upside)
Welby Inc.'s overall stock score is primarily hindered by its financial performance, characterized by declining revenues and negative profitability, which outweigh the positive technical indicators suggesting short-term momentum. The unfavorable valuation due to negative earnings further impacts the score.

Welby Inc. (4438) vs. iShares MSCI Japan ETF (EWJ)

Welby Inc. Business Overview & Revenue Model

Company DescriptionWelby Inc. (4438) is a company operating in the healthcare technology sector, specializing in digital health solutions. The company develops and provides platforms and services that enable efficient management and delivery of healthcare information. Its offerings are designed to improve patient engagement, streamline healthcare operations, and enhance data analytics for healthcare providers.
How the Company Makes MoneyWelby Inc. generates revenue primarily through the sale and licensing of its digital health platforms and services to healthcare providers, hospitals, and clinics. The company may also offer subscription-based models for ongoing access to its software solutions and data analytics tools. Additionally, Welby Inc. could engage in strategic partnerships with other technology firms and healthcare organizations to expand its reach and enhance its product offerings, further driving revenue. Key revenue streams likely include direct sales, subscription fees, and potentially consulting or implementation services related to its solutions.

Welby Inc. Financial Statement Overview

Summary
Welby Inc. faces financial challenges with declining revenue, negative profitability, and cash flow issues. Despite its strong equity position and low debt, the company needs to improve operational efficiency and profitability to ensure long-term sustainability. The persistent negative cash flows and net income highlight the need for strategic realignment to drive growth and manage expenses effectively.
Income Statement
35
Negative
Welby Inc. has experienced declining total revenue over the past years, with a significant decrease from 2019 to 2024. The gross profit margin remains relatively high, but the company has consistently reported negative net income, leading to negative net profit margins. The EBIT and EBITDA margins are also negative, indicating operational inefficiencies and challenges in managing expenses.
Balance Sheet
60
Neutral
The company maintains a strong equity ratio, suggesting a solid capital structure with low reliance on debt. The debt-to-equity ratio is low, which indicates low financial leverage. However, the return on equity is negative due to continuous losses, which raises concerns about shareholder value creation.
Cash Flow
40
Negative
Welby Inc. exhibits negative operating and free cash flows, which are concerning for liquidity and operational sustainability. The free cash flow to net income ratio is not favorable due to significant losses. However, the company has managed to maintain a substantial level of cash and short-term investments, which provides some financial cushion.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue528.04M575.00M1.05B1.14B864.64M
Gross Profit379.92M376.00M755.44M683.91M506.30M
EBITDA-792.75M-435.00M40.29M-127.70M-309.28M
Net Income-804.60M-505.00M33.91M-130.68M-353.09M
Balance Sheet
Total Assets1.17B1.21B1.40B1.39B1.52B
Cash, Cash Equivalents and Short-Term Investments740.43M883.00M830.82M960.72M1.10B
Total Debt200.00M1.00M8.35M15.49M22.63M
Total Liabilities328.90M88.00M121.40M134.83M162.60M
Stockholders Equity810.02M1.09B1.27B1.26B1.36B
Cash Flow
Free Cash Flow-776.25M-177.00M-146.86M-115.46M-155.09M
Operating Cash Flow-603.63M-174.00M-114.11M-95.95M-110.97M
Investing Cash Flow-235.84M235.61M-7.04M-34.56M-19.48M
Financing Cash Flow696.54M-8.75M-8.74M-7.14M20.00M

Welby Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price368.00
Price Trends
50DMA
355.84
Positive
100DMA
341.95
Positive
200DMA
357.57
Positive
Market Momentum
MACD
1.91
Negative
RSI
55.40
Neutral
STOCH
44.10
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4438, the sentiment is Positive. The current price of 368 is above the 20-day moving average (MA) of 362.15, above the 50-day MA of 355.84, and above the 200-day MA of 357.57, indicating a bullish trend. The MACD of 1.91 indicates Negative momentum. The RSI at 55.40 is Neutral, neither overbought nor oversold. The STOCH value of 44.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4438.

Welby Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (46)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
¥3.47B13.49
1.86%4.08%94.18%
70
Outperform
¥20.77B21.20
1.48%17.20%20.25%
53
Neutral
¥3.05B
-4.68%-62.31%
50
Neutral
¥4.03B
-7.73%-303.99%
46
Neutral
C$203.97M-3.15-23.14%2.72%21.17%-0.61%
45
Neutral
¥10.31B
-79.38%-1239.83%
43
Neutral
¥16.03B4,465.71
1.58%-7.98%-181.00%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4438
Welby Inc.
367.00
-183.00
-33.27%
JP:3902
Medical Data Vision Co.Ltd.
420.00
-151.04
-26.45%
JP:3939
Kanamic Network Co., LTD.
438.00
-112.36
-20.42%
JP:4263
SUSMED,Inc.
613.00
17.00
2.85%
JP:6034
MRT Inc.
701.00
-102.00
-12.70%
JP:6545
internet infinity INC.
645.00
215.10
50.03%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 10, 2025